Compliance with hormone replacement therapy at Songklanagarind Hospital

Journal of Obstetrics and Gynaecology Research

Volumn 29, Issue 6, 2003, Pages 380-387

  Wattanakumtornkul, Saranya ^a   Chichareon, Saibua ^a   Geater, Alan ^a   Suwan, Kobkaew ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Compliance; Discontinuation; Hormone replacement; Menopause; Non compliance

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; MEDROXYPROGESTERONE ACETATE; NORGESTREL; SEX HORMONE; TIBOLONE;

ADULT; AGRICULTURAL WORKER; ARTICLE; BLEEDING DISORDER; CANCER; CLIMACTERIUM; CONFIDENCE INTERVAL; CONTROLLED STUDY; EMPLOYEE; ENDOCRINE DISEASE; FEMALE; HORMONE SUBSTITUTION; HOSPITAL; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MENOPAUSE; OVARIECTOMY; OVARY INSUFFICIENCY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SIDE EFFECT; SYMPTOMATOLOGY; THAILAND; TREATMENT WITHDRAWAL;

COHORT STUDIES; COUNSELING; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; THAILAND; TREATMENT REFUSAL;

EID: 0842303614     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1341-8076.2003.00132.x     Document Type: Article

References (37)

1. Te Velde ER, Van Leusden HA. Hormonal treatment for the climacteric: Alleviation of symptoms and prevention of post-menopausal disease. Lancet 1994; 343: 654-658.
2. Barrett-Connor E. Hormone replacement therapy. BMJ 1998; 317: 457-461.
3. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102: 319-324.
4. Lobo RA, Speroff L. International consensus conference on postmenopausal hormone therapy and the cardio-vascular system. Fertil Steril 1994; 62 (Suppl): S176-S179.
5. Cauley JA, Seeley DG, Ensrud K et al. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995; 122: 9-16.
6. Studd J, Panay N, Zamblera D, Leather AT. HRT and long-term compliance: The efficacy and safety of Menorest®. Int J Gynecol Obstet 1996; 52 (Suppl 1): S21-S25.
7. Rees MCP. The need to improve compliance to HRT. Br J Obstet Gynaecol 1997; 104 (Suppl 16): 1-3.
8. Maclennan AH, Maclennan A, Wilson D. The prevalence of estrogen therapy in South Australia. Maturitas 1993; 16: 175-183.
9. Hammond CB. Women's concerns with hormone replacement therapy: Compliance issues. Fertil Steril 1994; 62: S157-S160.
10. Eiken P, Kolthoff N. Compliance with long-term oral hormonal replacement therapy. Maturitas 1995; 22: 97-103.
11. Doren M, Schneider HPG. Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. Maturitas 1996; 25: 99-105.
12. Udoff L, Adashi EY. Combined continuous hormone replacement therapy: A critical review. Obstet Gynecol 1995; 86: 306-316.
13. Vestergaard P, Hermann AP, Gram J et al. Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 1997; 28: 137-145.
14. Chung THK, Lau TK, Cheung LP, Haines CJ. Compliance with hormone replacement therapy in Chinese women in Hong Kong. Maturitas 1998; 28: 213-219.
15. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England Communities. Am J Epidemiol 1993; 137: 1125-1135.
16. Chiaffarino F, Parazzini F, La Vecchia C et al. Correlates of hormone replacement therapy use in Italian women, 1992-96. Maturitas 1999; 33: 107-115.
17. Jensen LB, Hilden J. Sociological and behavioural characteristics of perimenopausal women with an express attitude to hormone substitution therapy. Maturitas 1996; 23: 73-83.
18. Oddens BJ, Boulet MJ. Hormone replacement therapy among Danish women aged 45-65 years: Prevalence, determinants, and compliance. Obstet Gynecol 1997; 90: 269-277.
19. Schneider HPG, Gallagher JC. Moderation of the daily dose of HRT: Benefits for patients. Maturitas 1999; 33: S25-S29.
20. Tonkelaar ID, Oddens BJ. Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gynecol 2000; 95: 507-512.
21. Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992; 99: 325-328.
22. Ahmed AIH, Ryan PJ, Snelling T, Blake GM, Rymer J, Fogelman I. Long term compliance with hormone replacement treatment following screening for postmenopausal osteoporosis by bone density measurements. J Obstet Gynaecol 1996; 16: 41-44.
23. Doren M, Reuther G, Minne HW, Schneider HPG. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 1995; 173: 1446-1451.
24. Handrup YA, Obel EB, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand 2000; 79: 194-201.
25. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994; 140: 439-452.
26. Hemminki E, Brambilla DJ, McKinlay SM, Posner JG. Use of estrogens among middle-aged Massachusetts women. Drug Intell Clin Pharm 1991; 25: 418-425.
27. Nachtigall LE. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol 1990; 75: S77-S80.
28. Stadberg E, Mattsson LA, Milson I. Women's attitudes and knowledge about the climacteric period and its treatment: A Swedish population-based study. Maturitas 1997; 27: 109-116.
29. Rozenberg S, Vandromme J, Kroll M, Vasquez JB. Managing the climacteric. Int J Fertil 1999; 44: 12-18.
30. Van Seumeren I. Weight gain and hormone replacement therapy: Are women's fears justified? Maturitas 2000; 34: S3-S8.
31. Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987; 156: 1332-1334.
32. Bjorn I, Backstrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999; 32: 77-86.
33. Buist DS, LaCroix AZ, Newton KM, Keean NL. Are long-term hormone replacement therapy users different from short-term and never users? Am J Epidemiol 1999; 149: 275-281.
34. Hammond CB. Women's concerns with hormone replacement therapy-compliance issues. Fertil Steril 1994; 62 (Suppl 2): S157-S160.
35. Stumpf PG, Trolice MP. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin North Am 1994; 21: 219-228.
36. American College of Physicians. Guidelines for counselling postmenopausal women about preventive hormone therapy. Ann Int Med 1992; 117: 1038-1041.
37. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.